Related Experiment Videos
Critical mass retinopathy of prematurity: what is it and what can you do about it?
1Alberta Children's Hospital, Calgary, Canada.
Insights
Optimal treatment for retinopathy of prematurity (ROP) involves intervention during Stage 3b+ progression, targeting the avascular retina. Simultaneous treatment of multiple ROP sites increases complications, necessitating careful timing and location selection.
Area of Science:
- Ophthalmology
- Neonatal Medicine
- Retinal Diseases
Background:
- Retinopathy of prematurity (ROP) is a significant cause of visual impairment in premature infants.
- Advanced stages of ROP (Stage 3b, 3c, Stage 4) require timely and effective intervention to prevent severe visual loss.
- Previous treatment modalities have varied, with ongoing research into optimal timing, location, and methods.
Purpose of the Study:
- To summarize clinical experience in treating retinopathy of prematurity (ROP) in 41 patients.
- To evaluate the efficacy and outcomes of cryotherapy and Argon laser photocoagulation for advanced ROP.
- To identify optimal intervention timing and treatment locations to minimize complications.
Main Methods:
- Treatment of 76 eyes with Stage 3b, 3c, and Stage 4 ROP between November 1976 and June 1988.
- Application of cryotherapy to the ridge-EFP complex, avascular retina, or both.
- Two cases also received Argon laser photocoagulation.
- Comparison of outcomes with other major ROP studies.
Main Results:
- 7.9% of treated eyes developed Grade III to V RLF (retrolental fibroplasia).
- Optimal timing for intervention is during the progression of Stage 3b+ ROP.
- Treating the avascular retina appears most effective; treating both avascular retina and ridge-EFP simultaneously increased Grade II RLF and macular pigment epitheliopathy.
- The U.S. Cryo-ROP Study showed a higher rate of severe RLF, potentially due to later intervention.
Conclusions:
- Intervention during Stage 3b+ ROP progression is recommended.
- Targeting the avascular retina is the preferred treatment location.
- Simultaneous treatment of multiple ROP areas should be avoided to reduce complications.
- Careful consideration of intervention timing and location is crucial for successful ROP management.
Abstract:
This paper presents a summary of my experience with treatment of 41 patients with retinopathy of prematurity. From November, 1976, to June, 1988, 76 eyes with Stage 3b, 3c, and Stage 4 ROP had treatment to the ridge-EFP complex, the avascular retina, or both locations. Cryotherapy was used in all eyes, with two having Argon laser photocoagulation as well. These studies have shown that: 7.9% of all treated eyes had Grade III to V RLF; the optimal timing of intervention is recommended during progression of Stage 3b+ ROP; the optimal location of treatment appears to be the avascular retina with the ridge-EFP perhaps as effective but the treatment of both areas simultaneously is to be avoided due to an increased occurrence of grade II RLF and macular pigment epitheliopathy in those eyes so treated. A comparison of results of four major studies indicate that the U.S. Cryo-ROP Study has three times the rate of Grade III to V RLF, probably because of intervention after the accumulation of excessive quantities of Stage 3b and/or 3c ROP.